Clinical Trials Browser

Phase 2 × Unknown × Carcinoma, Small Cell × Clear all

NCT00906061 2009-05-21

Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell